loader

Disclaimer

The Bar Council of India does not permit advertisement or solicitation by advocates in any form or manner. By accessing this website, www.khaitanco.com, you acknowledge and confirm that you are seeking information relating to Khaitan & Co of your own accord and that there has been no form of solicitation, advertisement or inducement by Khaitan & Co or its members. The content of this website is for informational purposes only and should not be interpreted as soliciting or advertisement. No material/information provided on this website should be construed as legal advice. Khaitan & Co shall not be liable for consequences of any action taken by relying on the material/information provided on this website. The contents of this website are the intellectual property of Khaitan & Co.

Please accept the above
Close

Search

See all results for ""

Firm Matters

Amneal Pharmaceuticals LLC to Acquire 100% stake in Kashiv Biosciences LLC

  • 01-May-2026

Khaitan & Co is representing Amneal Pharmaceuticals, LLC (Amneal) as India counsels, alongside Simpson Thacher & Bartlett LLP in relation to its announced agreement to acquire 100% of Kashiv Biosciences LLC ("Kashiv"), a vertically integrated biopharmaceutical company incorporated in the United States of America, with 2 (two) subsidiaries in India (namely, Kashiv Biosciences Pvt Ltd and Kashiv Research Pvt Ltd), in a transaction with consideration that includes USD 375 million of cash and USD 375 million of equity payable at closing, plus up to USD 350 million in potential payments based on the achievement of certain regulatory milestones, potential royalties based on commercial milestones, and funding of operations through closing.

The transaction is expected to close in the second half of 2026, subject to approval by Amneal’s shareholders, regulatory approvals and customary closing conditions. 

The Firm acted as India counsels to Amneal, alongside Simpson Thacher & Bartlett LLP, to assist with undertaking legal and tax due diligence, providing India law structuring advisory and finalising transaction documentation.

Deal Team

Amneal Pharmaceuticals

The core team consisted of Rabindra Jhunjhunwala (Partner), Sameer Sah (Partner), Aman Anand (Counsel), Sayani Bhattacharyya (Principal Associate) and Manya Vipin Chugh (Associate).

Direct Tax: Ritu Shaktawat (Partner), Rahul Jain (Partner), Avin Jain (Principal Associate) and Jinisha Jain (Senior Associate)

Employment Labour & Benefitss: Vinay Joy (Partner), Srishti Ramkrishnan (Partner), Aditya J Nair (Senior Associate) and Ajay Kranthi Kothwal (Associate)

Indirect Tax: Sudipta Bhattacharjee (Partner) and Arjyadeep Roy (Principal Associate)

Intellectual Property: Shailendra Bhandare (Partner) and Vaishali Adhikari (Senior Associate)

Real Estate: Mudit Shah and Nidhi Marakana (Associate)

Competition / Antitrust: Anisha Chand (Partner), Rishabh Vohra (Senior Associate) and Shubhanshu Jain (Associate)

Banking & Finance: Ahana Sinha (Partner), Krishnendu Sen (Counsel), Arindam Bhattacharjee (Principal Associate), Sushmit Mandal (Associate) and Aaryan Mohan (Associate)

Privacy and Data Protection: Harsh Walia (Partner), Shobhit Chandra (Counsel) and Khyati Goel (Senior Associate)